Zhang, M., Yao, Z., Dubois, S., Ju, W., Müller, J. R., & Waldmann, T. A. (2009). Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer. National Academy of Sciences.

Zhang, Meili, Zhengsheng Yao, Sigrid Dubois, Wei Ju, Jürgen R. Müller, und Thomas A. Waldmann. Interleukin-15 Combined With an Anti-CD40 Antibody Provides Enhanced Therapeutic Efficacy for Murine Models of Colon Cancer. National Academy of Sciences, 2009.

Zhang, Meili, et al. Interleukin-15 Combined With an Anti-CD40 Antibody Provides Enhanced Therapeutic Efficacy for Murine Models of Colon Cancer. National Academy of Sciences, 2009.